Dexco S.A.

BOVESPA:DXCO3 주식 리포트

시가총액: R$5.2b

Dexco 향후 성장

Future 기준 점검 4/6

Dexco (는) 각각 연간 60.9% 및 6.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 62.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 7.4% 로 예상됩니다.

핵심 정보

60.9%

이익 성장률

62.05%

EPS 성장률

Forestry 이익 성장23.4%
매출 성장률6.5%
향후 자기자본이익률7.43%
애널리스트 커버리지

Good

마지막 업데이트11 May 2026

최근 향후 성장 업데이트

Recent updates

내러티브 업데이트 • May 02

DXCO3: Future Stock Split Will Support More Attractive Multiple Repricing Outlook

Analysts have raised their price target on Dexco from approximately R$7.16 to about R$7.28, citing updated assumptions regarding the discount rate, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: R$7.16 to R$7.28, representing a small upward adjustment in the modelled target price range.
내러티브 업데이트 • Apr 18

DXCO3: Higher Revenue Outlook And Richer Future P/E Will Support Upside

Analysts have raised their valuation of Dexco, increasing the fair value estimate from R$8.70 to R$9.00. The change reflects updated assumptions that include higher revenue growth expectations, a lower discount rate and a richer future P/E multiple, partly offset by a lower projected profit margin.
내러티브 업데이트 • Apr 04

DXCO3: Future Stock Split Will Support A More Attractive Repricing Outlook

Analysts have slightly adjusted their R$ price target on Dexco, citing updated assumptions that combine a different fair value estimate with changes to revenue growth, profit margin expectations and a higher future P/E multiple. Valuation Changes Fair Value: R$7.22 in the previous model compared with R$7.16 in the updated assumptions.
내러티브 업데이트 • Mar 21

DXCO3: Planned Stock Split And Margin Outlook Will Support Future Upside

Analysts have kept their R$ fair value estimate for Dexco steady at R$5.36. Updated assumptions reflect a slightly higher discount rate, a marginally lower revenue growth outlook, a modestly stronger profit margin, and a similar future P/E expectation.
내러티브 업데이트 • Mar 06

DXCO3: Planned Stock Split Will Support Positive Long Term Outlook

Analysts have revised their R$ price target for Dexco slightly, with the change grounded in updated assumptions that include a different discount rate, adjusted revenue growth and profit margin expectations, and a revised future P/E multiple. What's in the News Dexco plans a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).
내러티브 업데이트 • Feb 20

DXCO3: Future Stock Split Will Support A More Attractive Share Repricing

Analysts have trimmed their R$ price target for Dexco, reflecting a slightly lower fair value estimate alongside updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Dexco announced a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).
내러티브 업데이트 • Feb 06

DXCO3: Stock Split And Conservative Earnings Profile Will Support Future Upside

Analysts have reduced their fair value estimate for Dexco from about $8.81 to $8.70 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E, which collectively indicate a more conservative earnings profile than previously estimated.
내러티브 업데이트 • Jan 23

DXCO3: Future Split And Revised Assumptions Will Shape Balanced Outlook

Analysts have reduced their fair value estimate for Dexco from US$6.00 to US$5.36, citing updated assumptions for revenue growth, profit margins, the discount rate, and a lower future P/E multiple. What's in the News Dexco has announced a stock split or significant stock dividend with a 1.12 to 1 ratio, scheduled for December 26, 2025 (Key Developments).
분석 기사 • Jan 23

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
내러티브 업데이트 • Jan 08

DXCO3: Future Margins And Stock Split Plan Will Support Upside

Analysts have adjusted their price target for Dexco, reflecting a fair value change from $9.83 to $8.81. This shift is tied to updated assumptions for revenue growth, profit margins and future P/E expectations.
분석 기사 • Dec 25

Dexco S.A. (BVMF:DXCO3) Not Flying Under The Radar

With a price-to-earnings (or "P/E") ratio of 41.1x Dexco S.A. ( BVMF:DXCO3 ) may be sending very bearish signals at the...
내러티브 업데이트 • Dec 23

DXCO3: Stronger Future Margins And Investor Day May Drive Upside

Analysts have adjusted their price target on Dexco from R$10.00 to roughly R$9.83 per share. This reflects slightly lower revenue growth assumptions, stronger expected profit margins, and a more conservative future valuation multiple.
분석 기사 • Nov 13

Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders

A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...
분석 기사 • Oct 06

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
내러티브 업데이트 • Sep 06

Urbanization Trends And Digital Platforms Will Expand Market Reach

With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.
분석 기사 • Mar 21

Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think

A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. Our analysis...
분석 기사 • Mar 15

Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Shareholders might have noticed that Dexco S.A. ( BVMF:DXCO3 ) filed its full-year result this time last week. The...
User avatar
새 내러티브 • Mar 10

New Ceramic Tiles Factory In Botucatu Will Improve Future Operations

Streamlining of operations could enhance focus on core areas, boosting profitability and improving net margins.
분석 기사 • Feb 12

Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
분석 기사 • Dec 20

Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?

While Dexco S.A. ( BVMF:DXCO3 ) might not have the largest market cap around , it saw significant share price movement...
분석 기사 • Dec 02

There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price

When close to half the companies in Brazil have price-to-earnings ratios (or "P/E's") below 8x, you may consider Dexco...
분석 기사 • Oct 26

Is Dexco (BVMF:DXCO3) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Aug 10

Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results

Shareholders of Dexco S.A. ( BVMF:DXCO3 ) will be pleased this week, given that the stock price is up 12% to R$8.05...
분석 기사 • Aug 08

Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a decent share price growth of 14% on the...
분석 기사 • Jul 19

Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...
분석 기사 • May 13

Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

Last week saw the newest quarterly earnings release from Dexco S.A. ( BVMF:DXCO3 ), an important milestone in the...
분석 기사 • May 04

Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?

Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a double-digit share price rise of over 10...
분석 기사 • Apr 15

Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
분석 기사 • Mar 14

Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem

Shareholders didn't seem to be thrilled with Dexco S.A.'s ( BVMF:DXCO3 ) recent earnings report, despite healthy profit...
분석 기사 • Jan 19

Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors

With a price-to-earnings (or "P/E") ratio of 7.5x Dexco S.A. ( BVMF:DXCO3 ) may be sending bullish signals at the...
분석 기사 • Jan 04

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 • Dec 04

At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?

Dexco S.A. ( BVMF:DXCO3 ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...
분석 기사 • Oct 08

Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
분석 기사 • Sep 13

Is Dexco (BVMF:DXCO3) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

이익 및 매출 성장 예측

BOVESPA:DXCO3 - 애널리스트 향후 추정치 및 과거 재무 데이터 (BRL Millions)
날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수
12/31/202810,0385538251,3446
12/31/20279,38548458692911
12/31/20268,7372898629992
12/31/20258,2491-69851N/A
9/30/20258,216111-6952N/A
6/30/20258,327193441,104N/A
3/31/20258,201258-161,240N/A
12/31/20248,235172-641,284N/A
9/30/20248,119337861,482N/A
6/30/20247,649542-61,440N/A
3/31/20247,607602391,352N/A
12/31/20237,383790981,346N/A
9/30/20237,415812-153975N/A
6/30/20237,808668-151993N/A
3/31/20238,068680-456726N/A
12/31/20228,487756-419794N/A
9/30/20228,7571,128151,226N/A
6/30/20228,7731,2291421,227N/A
3/31/20228,5331,7765501,505N/A
12/31/20218,1701,7258511,708N/A
9/30/20217,8131,4468631,585N/A
6/30/20217,4141,3151,3261,930N/A
3/31/20216,4865741,2891,813N/A
12/31/20205,8804541,0201,508N/A
9/30/20205,4724371,0891,536N/A
6/30/20205,0033417401,187N/A
3/31/20205,1014345781,050N/A
12/31/20195,0124066531,108N/A
9/30/20194,789-21N/A744N/A
6/30/20194,993327N/A445N/A
3/31/20195,016425N/A437N/A
12/31/20184,949432N/A383N/A
9/30/20184,789658N/A303N/A
6/30/20184,296365N/A356N/A
3/31/20184,045223N/A340N/A
12/31/20173,991185N/A405N/A
9/30/20173,917125N/A470N/A
6/30/20173,86472N/A346N/A
3/31/20173,96047N/A540N/A
12/31/20163,91024N/A451N/A
9/30/20163,83650N/A400N/A
6/30/20163,91148N/A493N/A
3/31/20163,86385N/A443N/A
12/31/20153,963183N/A574N/A
9/30/20154,048221N/A691N/A
6/30/20154,064275N/A837N/A

애널리스트 향후 성장 전망

수입 대 저축률: DXCO3 의 연간 예상 수익 증가율(60.9%)이 saving rate(12.4%)보다 높습니다.

수익 vs 시장: DXCO3 의 연간 수익(60.9%)이 BR 시장(12.6%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 수익: DXCO3 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: DXCO3 의 수익(연간 6.5%)이 BR 시장(연간 6.4%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: DXCO3 의 수익(연간 6.5%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: DXCO3의 자본 수익률은 3년 후 7.4%로 낮을 것으로 예상됩니다.

성장 기업 찾아보기

7D

1Y

7D

1Y

7D

1Y

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/05/12 03:18
종가2026/05/11 00:00
수익2025/12/31
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Dexco S.A.는 16명의 분석가가 다루고 있습니다. 이 중 11명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Guilherme RositoBofA Global Research
Rafael BarcellosBradesco S.A. Corretora de Títulos e Valores Mobiliários
Carlos Palhares SequeiraBTG Pactual